APO Research
Talk to an analyst

APO RESEARCH · REPORT

End-Stage Renal Disease (ESRD) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global End-Stage Renal Disease (ESRD) Drugs Industry Growth and Trends Forecast to 2032

19 December 202591 pages

Choose your research edition.

Industry ResearchEnd-Stage Renal Disease (ESRD) Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal End-Stage Renal Disease (ESRD) Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal End-Stage Renal Disease (ESRD) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal End-Stage Renal Disease (ESRD) Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal End-Stage Renal Disease (ESRD) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global End-Stage Renal Disease (ESRD) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for End-Stage Renal Disease (ESRD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for End-Stage Renal Disease (ESRD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for End-Stage Renal Disease (ESRD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of End-Stage Renal Disease (ESRD) Drugs include Novartis AG, Merck & Co Inc, VESSL Therapeutics Ltd, Prolong Pharmaceuticals LLC and CTI BioPharma Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global End-Stage Renal Disease (ESRD) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The End-Stage Renal Disease (ESRD) Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global End-Stage Renal Disease (ESRD) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to End-Stage Renal Disease (ESRD) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global End-Stage Renal Disease (ESRD) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

End-Stage Renal Disease (ESRD) Drugs Market by Company

Novartis AG

Merck & Co Inc

VESSL Therapeutics Ltd

Prolong Pharmaceuticals LLC

CTI BioPharma Corp

End-Stage Renal Disease (ESRD) Drugs Segment by Type

Sanguinate

Tesidolumab

Calcium Succinate

Mk-3866

Pacritinib

Others

End-Stage Renal Disease (ESRD) Drugs Segment by Application

ICU

Hospital

Clinic

Others

End-Stage Renal Disease (ESRD) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global End-Stage Renal Disease (ESRD) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of End-Stage Renal Disease (ESRD) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of End-Stage Renal Disease (ESRD) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of End-Stage Renal Disease (ESRD) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of End-Stage Renal Disease (ESRD) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Sanguinate Table 2. Major Company of Tesidolumab Table 3. Major Company of Calcium Succinate Table 4. Major Company of Mk-3866 Table 5. Major Company of Pacritinib Table 6. Major Company of Others Table 7. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2021-2026) & (US$/Unit) Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2027-2032) & (K Units) Table 14. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2027-2032) & (US$/Unit) Table 18. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 19. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 21. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 25. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. End-Stage Renal Disease (ESRD) Drugs Industry Trends Table 29. End-Stage Renal Disease (ESRD) Drugs Industry Drivers Table 30. End-Stage Renal Disease (ESRD) Drugs Industry Opportunities and Challenges Table 31. End-Stage Renal Disease (ESRD) Drugs Industry Restraints Table 32. Global End-Stage Renal Disease (ESRD) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2021-2026) Table 34. Global End-Stage Renal Disease (ESRD) Drugs Sales by Company (2021-2026) & (K Units) Table 35. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Company (2021-2026) Table 36. Global End-Stage Renal Disease (ESRD) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global End-Stage Renal Disease (ESRD) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global End-Stage Renal Disease (ESRD) Drugs Major Company Production Sites and Headquarters Table 39. Global End-Stage Renal Disease (ESRD) Drugs Company, Product Type & Application Table 40. Global End-Stage Renal Disease (ESRD) Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global End-Stage Renal Disease (ESRD) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 56. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2021-2026) & (US$/Unit) Table 60. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2027-2032) & (K Units) Table 61. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2027-2032) & (US$/Unit) Table 65. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 66. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 68. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 72. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Portfolio Table 79. Novartis AG Recent Development Table 80. Merck & Co Inc Company Information Table 81. Merck & Co Inc Business Overview Table 82. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Portfolio Table 84. Merck & Co Inc Recent Development Table 85. VESSL Therapeutics Ltd Company Information Table 86. VESSL Therapeutics Ltd Business Overview Table 87. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Portfolio Table 89. VESSL Therapeutics Ltd Recent Development Table 90. Prolong Pharmaceuticals LLC Company Information Table 91. Prolong Pharmaceuticals LLC Business Overview Table 92. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Portfolio Table 94. Prolong Pharmaceuticals LLC Recent Development Table 95. CTI BioPharma Corp Company Information Table 96. CTI BioPharma Corp Business Overview Table 97. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Portfolio Table 99. CTI BioPharma Corp Recent Development Table 100. North America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 101. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026) & (K Units) Table 102. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2021-2026) Table 103. North America End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 104. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 105. North America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 106. North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 107. North America End-Stage Renal Disease (ESRD) Drugs Market Share by Country (2021-2026) Table 108. North America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 109. North America End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Country (2027-2032) Table 110. Europe End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026) & (K Units) Table 112. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2021-2026) Table 113. Europe End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 114. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 115. Europe End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 117. Europe End-Stage Renal Disease (ESRD) Drugs Market Share by Country (2021-2026) Table 118. Europe End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. Europe End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Country (2027-2032) Table 120. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026) & (K Units) Table 122. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2021-2026) Table 123. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 124. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 127. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Share by Country (2021-2026) Table 128. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Country (2027-2032) Table 130. Latin America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026) & (K Units) Table 132. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2021-2026) Table 133. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 134. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 135. Latin America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 137. Latin America End-Stage Renal Disease (ESRD) Drugs Market Share by Country (2021-2026) Table 138. Latin America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Latin America End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Country (2027-2032) Table 140. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026) & (K Units) Table 142. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2021-2026) Table 143. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 144. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 147. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Share by Country (2021-2026) Table 148. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Country (2027-2032) Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. End-Stage Renal Disease (ESRD) Drugs Distributors List Table 153. End-Stage Renal Disease (ESRD) Drugs Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. End-Stage Renal Disease (ESRD) Drugs Image Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global End-Stage Renal Disease (ESRD) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global End-Stage Renal Disease (ESRD) Drugs Sales (2021-2032) & (K Units) Figure 5. Sanguinate Image Figure 6. Global Sanguinate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tesidolumab Image Figure 8. Global Tesidolumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Calcium Succinate Image Figure 10. Global Calcium Succinate Sales YoY Growth (2021-2032) & (K Units) Figure 11. Mk-3866 Image Figure 12. Global Mk-3866 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Pacritinib Image Figure 14. Global Pacritinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Type 2025 VS 2032 Figure 19. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 End-Stage Renal Disease (ESRD) Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. ICU Image Figure 32. Global ICU Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Application 2025 VS 2032 Figure 41. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America End-Stage Renal Disease (ESRD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America End-Stage Renal Disease (ESRD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe End-Stage Renal Disease (ESRD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe End-Stage Renal Disease (ESRD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America End-Stage Renal Disease (ESRD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. End-Stage Renal Disease (ESRD) Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. End-Stage Renal Disease (ESRD) Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Sanguinate
  • Tesidolumab
  • Calcium Succinate
  • Mk-3866
  • Pacritinib
  • Others
Applications
  • ICU
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co Inc
  • VESSL Therapeutics Ltd
  • Prolong Pharmaceuticals LLC
  • CTI BioPharma Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global End-Stage Renal Disease (ESRD) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 End-Stage Renal Disease (ESRD) Drugs Market by Type
  6. 1.3.1 Sanguinate
  7. 1.3.2 Tesidolumab
  8. 1.3.3 Calcium Succinate
  9. 1.3.4 Mk-3866
  10. 1.3.5 Pacritinib
  11. 1.3.6 Others
  12. 1.4 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Type
  13. 1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 End-Stage Renal Disease (ESRD) Drugs Industry Trends
  2. 2.2 End-Stage Renal Disease (ESRD) Drugs Industry Drivers
  3. 2.3 End-Stage Renal Disease (ESRD) Drugs Industry Opportunities and Challenges
  4. 2.4 End-Stage Renal Disease (ESRD) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Price (2021-2026)
  4. 3.4 Global End-Stage Renal Disease (ESRD) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global End-Stage Renal Disease (ESRD) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global End-Stage Renal Disease (ESRD) Drugs Company, Product Type & Application
  7. 3.7 Global End-Stage Renal Disease (ESRD) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global End-Stage Renal Disease (ESRD) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 End-Stage Renal Disease (ESRD) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 End-Stage Renal Disease (ESRD) Drugs Tier 1, Tier 2, and Tier 3
4 End-Stage Renal Disease (ESRD) Drugs Regional Status and Outlook
  1. 4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Region
  3. 4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global End-Stage Renal Disease (ESRD) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global End-Stage Renal Disease (ESRD) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 End-Stage Renal Disease (ESRD) Drugs by Application
  1. 5.1 End-Stage Renal Disease (ESRD) Drugs Market by Application
  2. 5.1.1 ICU
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Others
  6. 5.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application
  7. 5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck & Co Inc
  8. 6.2.1 Merck & Co Inc Company Information
  9. 6.2.2 Merck & Co Inc Business Overview
  10. 6.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Portfolio
  12. 6.2.5 Merck & Co Inc Recent Developments
  13. 6.3 VESSL Therapeutics Ltd
  14. 6.3.1 VESSL Therapeutics Ltd Company Information
  15. 6.3.2 VESSL Therapeutics Ltd Business Overview
  16. 6.3.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Portfolio
  18. 6.3.5 VESSL Therapeutics Ltd Recent Developments
  19. 6.4 Prolong Pharmaceuticals LLC
  20. 6.4.1 Prolong Pharmaceuticals LLC Company Information
  21. 6.4.2 Prolong Pharmaceuticals LLC Business Overview
  22. 6.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Portfolio
  24. 6.4.5 Prolong Pharmaceuticals LLC Recent Developments
  25. 6.5 CTI BioPharma Corp
  26. 6.5.1 CTI BioPharma Corp Company Information
  27. 6.5.2 CTI BioPharma Corp Business Overview
  28. 6.5.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Portfolio
  30. 6.5.5 CTI BioPharma Corp Recent Developments
7 North America by Country
  1. 7.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country
  2. 7.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
  6. 7.2.1 North America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country
  2. 8.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country
  6. 8.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America End-Stage Renal Disease (ESRD) Drugs Sales by Country
  2. 10.1.1 South America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
  6. 10.2.1 South America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 End-Stage Renal Disease (ESRD) Drugs Value Chain Analysis
  2. 12.1.1 End-Stage Renal Disease (ESRD) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 End-Stage Renal Disease (ESRD) Drugs Production Mode & Process
  7. 12.2 End-Stage Renal Disease (ESRD) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 End-Stage Renal Disease (ESRD) Drugs Distributors
  10. 12.2.3 End-Stage Renal Disease (ESRD) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst